Silk Road Medical (Nasdaq:SILK) announced today that it appointed Chas McKhann as its new CEO, effective immediately. Located in Sunnyvale, California and Plymouth, Minnesota, Silk Road Medical is focused on reducing stroke risk through a carotid artery disease treatment called TransCarotid Artery Revascularization (TCAR). The company announced last month that CEO Erica Rogers intended to […]
Silk Road Medical
Silk Road Medical CEO announces retirement
Silk Road Medical (Nasdaq:SILK) today announced that CEO Erica Rogers plans to retire from the company. Rogers will formally retire once the succession process is completed. The Sunnyvale, California-based company is working with executive search firm Spencer Stuart to find a replacement CEO. “I’d like to thank Erica for her tremendous contributions to Silk Road […]
Silk Road Medical ticks up on Street-beating Q3 results
Silk Road Medical (NSDQ:SILK) this week posted third-quarter results that beat the overall consensus on Wall Street. The Sunnyvale, California-based stroke treatment tech company reported net losses of $10.3 million, or -29¢ per share, on sales of $37.4 million for the three months ended Sept. 30, on sales growth of 51.31% and profit gain from […]
Silk Road Medical announces $100M offering
Silk Road Medical (NSDQ:SILK) announced that it commenced a proposed underwritten public offering of $100 million in common stock. The Sunnyvale, California–based stroke treatment tech company plans to use proceeds to expand its sales force and operations. It also intends to increase its R&D activities, conduct or sponsor clinical trials and lease new facilities. Silk […]
Silk Road Medical grows sales 27% in Q1 results
Silk Road Medical (NSDQ:SILK) this week posted first-quarter results that beat the revenue consensus on Wall Street and missed on earnings. The Sunnyvale, California-based stroke treatment tech company reported losses of $16.7 million, or -48¢ per share, on sales of $28.02 million for the three months ended March 31 for sales growth of 27% compared […]
Silk Road Medical grows sales 33% in Q4
Silk Road Medical (NSDQ:SILK) posted fourth-quarter results that beat the revenue consensus on Wall Street and missed on earnings estimates. The Sunnyvale, California-based stroke treatment tech company reported losses of -$14.7 million, or -42¢ per share, on sales of $28.3 million for the three months ended Dec. 31, 2021, for a bottom-line gain of 12.3% […]
